Home > Press > Izon Science granted core patents for elastomeric nanopore technology
Abstract:
Nanotechnology instrument manufacturer Izon Science today announced core patents for its nano and bio particle analysis platform. The United States Patent and Trademark Office (USPTO) has accepted Izon Science Patent No. 11/721047 for an invention for detecting, measuring and controlling particles. The patent covers the novel elastomeric size-tunable nanopores used in Izon Science's qNano and qViro instruments.
Izon Science granted core patents for elastomeric nanopore technology
Christchurch, New Zealand | Posted on June 9th, 2012
The Australian Patent Office has also accepted Izon Science Patent No. 2005315729 for the same core technology.
Izon Science has also been granted a patent for its analysis platform by the UK Intellectual Property Office. UK Patent No. 2477287 (formerly Application No. 1001311.8) for Control of particle flow in an aperture and relates to the use of combined pressure and voltage. This follows on from the prior award of the core patent in 2006 (GB2421303, 12 November 2006).
"Acceptance of these patents is a major milestone for the company. We're now selling our instrumentation in over 30 countries and are rapidly expanding our patent portfolio, core measurement capabilities and R&D capability," says Hans van der Voorn, Executive Chairman of Izon Science.
Van der Voorn says the company is experiencing high growth, in all areas where it operates. "We're now able to do R&D in our Boston and Oxford offices in addition to the work at our headquarters in Christchurch, New Zealand. By extending our R&D base we're able to work on more collaborative research which is very valuable for the company and its customers and research partners."
Izon Science is the developer of the portable qNano and qViro instruments with unique size-tunable nanopores. The multi-parameter instruments offer significant accuracy and reliability improvements over previously available techniques and are advancing research in a number of fields including nanomedicine, hematology, gene therapy and vaccine development.
####
About Izon Science
Izon Science has developed the world’s first nanopore based measurement system available for general use. Izon’s instruments are used for precise measurement and analysis of individual particles across a wide range of scientific fields including, nanomedicine, vaccinology, gene therapy and hematology. Izon originated in New Zealand and now sells its products in 30 countries. It has its European headquarters in Oxford, UK and US headquarters in Cambridge, MA.
For more information, please click here
Contacts:
Hans van der Voorn
Executive Chairman
Izon Science
Phone: + 64 21 463 399
Sandra Lukey
Shine Group
Phone: + 64 21 2262 858
Copyright © Izon Science
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Izon Science on Facebook:
Izon Science on Twitter:
News and information
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Nanomedicine
Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013
Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Tools
NanoInk, Inc. Assets To Be Sold May 18th, 2013
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
DNA-Guided Assembly Yields Novel Ribbon-Like Nanostructures: Approach could be useful in fabricating new kinds of materials with engineered properties May 16th, 2013
Patents/IP/Tech Transfer/Licensing
NanoInk, Inc. Assets To Be Sold May 18th, 2013
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone May 7th, 2013